Skip to main content
. 2022 Apr 19;22:423. doi: 10.1186/s12885-022-09516-1

Fig. 4.

Fig. 4

Activation of YAP/TAZ and EGFR/HER2 signaling pathways in human liver cancers. Microscopic images showing IHC staining for YAP, TAZ, pEGFR, and phosphorylated downstream effector molecules of EGFR/HER2 in human HCC and CC. Scale bar, 50 μm